Detalhe da pesquisa
1.
Interferon-ε is a tumour suppressor and restricts ovarian cancer.
Nature
; 620(7976): 1063-1070, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37587335
2.
Ovarian cancer mutational processes drive site-specific immune evasion.
Nature
; 612(7941): 778-786, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36517593
3.
Genomics to select treatment for patients with metastatic breast cancer.
Nature
; 610(7931): 343-348, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36071165
4.
The impact of coding germline variants on contralateral breast cancer risk and survival.
Am J Hum Genet
; 110(3): 475-486, 2023 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36827971
5.
Rucaparib or Physician's Choice in Metastatic Prostate Cancer.
N Engl J Med
; 388(8): 719-732, 2023 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36795891
6.
Exome sequencing and characterization of 49,960 individuals in the UK Biobank.
Nature
; 586(7831): 749-756, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33087929
7.
Quantitative Activity Profile and Context Dependence of All Human 5' Splice Sites.
Mol Cell
; 71(6): 1012-1026.e3, 2018 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30174293
8.
BRCA2 chaperones RAD51 to single molecules of RPA-coated ssDNA.
Proc Natl Acad Sci U S A
; 120(14): e2221971120, 2023 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36976771
9.
Tumour lineage shapes BRCA-mediated phenotypes.
Nature
; 571(7766): 576-579, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292550
10.
Germline testing of BRCA1, BRCA2, PALB2 and CHEK2 c.1100delC in 1514 triple negative familial and isolated breast cancers from a single centre, with extended testing of ATM, RAD51C and RAD51D in over 400.
J Med Genet
; 61(4): 385-391, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38123987
11.
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.
N Engl J Med
; 384(25): 2394-2405, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34081848
12.
BRCA2 Polymorphisms and Breast Cancer Susceptibility: a Multi-Tools Bioinformatics Approach.
Cell Physiol Biochem
; 58(2): 128-143, 2024 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38623065
13.
Pathogenic variants in human DNA damage repair genes mostly arose in recent human history.
BMC Cancer
; 24(1): 415, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38575974
14.
Germline mutations in BRCA1 and BRCA2 among Brazilian women with ovarian cancer treated in the Public Health System.
BMC Cancer
; 24(1): 499, 2024 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38641594
15.
Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan.
J Biomed Sci
; 31(1): 21, 2024 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38350919
16.
Missed therapeutic and prevention opportunities in women with BRCA-mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: A review of the literature.
CA Cancer J Clin
; 67(6): 493-506, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28881380
17.
Clinical characterization of patients with gBRCA1/2 mutation-positive unresectable pancreatic cancer: a multicenter prospective study.
Jpn J Clin Oncol
; 54(1): 47-53, 2024 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37791389
18.
Clinical and psychological implications of secondary and incidental findings in cancer susceptibility genes after exome sequencing in patients with rare disorders.
J Med Genet
; 60(7): 685-691, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36446584
19.
Adaptive nanopore sequencing to determine pathogenicity of BRCA1 exonic duplication.
J Med Genet
; 60(12): 1206-1209, 2023 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37263769
20.
Contribution of large genomic rearrangements in PALB2 to familial breast cancer: implications for genetic testing.
J Med Genet
; 60(2): 112-118, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35396271